Michael Dujela, DPM
Podiatrist · Centralia, WANPI 1083719876
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $61,328 of the $99,043 with a category attached, or 61.9%. 9 manufacturers reported payments, led by Paragon 28, Inc. at 38.4% of the total. Reporting peaked in 2023 at $41,274 and has fallen 69.8% since, to $12,467 in 2025. Among podiatrist clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $876.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$38K
- Medical Device Business Services, Inc.$26K
- Synthes GmbH$16K
- Treace Medical Concepts, Inc.$13K
- Voom Medical Devices, Inc.$4K
- Stryker$561
- plus $615 from 3 others
What the payments were for
- Consulting fees$61,32862%
- Speaking & faculty fees$9,0009%
- Travel & lodging$24,57625%
- Food & beverage$4,1404%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 45 | $38,051 |
| Medical Device Business Services, Inc. | 25 | $25,870 |
| Synthes GmbH | 20 | $16,359 |
| Treace Medical Concepts, Inc. | 9 | $13,180 |
| Voom Medical Devices, Inc. | 4 | $4,407 |
| Stryker(2 entities) | 5 | $561 |
| Medline Industries LP | 3 | $458 |
| Invictus Surgical Incorporated | 1 | $82 |
| Linvatec Corporation | 1 | $75 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Portfolio$35,574
- Lapiplasty System$13,067
- REVCON INSTRUMENT KIT, STERILE$4,263
- Fibulink$1,742
- MEDLINE UNITE$748
- APEX 3D$738
- React$555
- TRAUMA$418
- AUGMENT INJECTABLE$167
- INBONE$158
- PHANTOM Hindfoot$150
- TAR$147
How this compares
$99,043 in reported general payments places this provider in the 95th percentile of 134 podiatrist providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 14 | $10,316 |
| EliquisApixaban | 14 | $10,174 |
| Gabapentin | 12 | $116 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Centralia
- Huy DangCentralia$63K
- Byron HutchinsonBurien$903K
- Michael FrazierFederal Way$27K
- Ryan StoneBurien$15K
- Alvin NganSeattle$13K
- Tony KimWenatchee$11K
- Anthony MollicaBellevue$11K
- Todd ChappellTacoma$9K
- Matthew WilliamsSeattle$8K
- Joshua SmithPuyallup$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.